Novo Nordisk trial with next-gen diabetes drug shows 15.7% weight loss but shares fall
Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...
Ozempic parent’s new weight-loss drug works better, but not quite good enough
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...
Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit
Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...
State funding logjam stalls up to 5,000 social and affordable homes
Good morning. Property dominates the business news this mornings with reports that work on up to 5,000 social and affordable ...
Opinion | Trump’s America: Threats, Tariffs, And A New World Order
The message is clear: if you want access to US markets, you must be willing to strike what President Trump considers a fair ...
YourLifeChoices4h
How Ozempic and other GLP-1 agonist drugs turn down ‘food noise’ and cravings
When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but ...
5 things to know before the stock market opens Monday
Stock futures fell again Monday, after the S&P 500 had its worst week in months amid fears about President Donald Trump's tariff policy. Mark Carney won the race to replace Justin Trudeau as Canada's ...
‘Weight-loss drugs seemed good alternative but...’: How Ozempic led to vision blindness disaster - survivor recounts
A US resident lost around 40 kilos using a weight-loss drug but developed vision problems, to be ultimately diagnosed with ...
Le Lézard1h
U.S. Medical Weight Loss Market Report 2025: The Impact of GLP-1s on Doctors, Hospitals, Clinics and Franchises - ResearchAndMarkets.com
The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete picture of the medical weight loss market in the ...